Rhythm Pharmaceuticals
The Senior Director, Analytical Development and Quality Control leads strategic and technical initiatives for analytical development and quality control across Rhythm's portfolio, overseeing method development, validation, and lifecycle management from discovery through commercialization. This role manages internal teams and external partners, ensures compliance with cGMP and regulatory requirements, and contributes to regulatory submissions and cross‑functional alignment.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
31% above the average for this role
Principal Scientist, Pharmaceutical Analytical Sciences
Merck & Co., Inc.
Principal Scientist, Pharmaceutical Analytical Sciences
Merck & Co., Inc.
Associate Director of CMC Analytical Development
Syncromune®
Associate Director/Director of CMC Analytical Development
Syncromune®
Principal Scientist, Pharmaceutical Analytical Sciences
MSD
Analytical Lead
Neurocrine Biosciences